Table 7.
Specific free fatty acids (FFA) in healthy controls (HC) and systemic lupus erythematosus (SLE) patients.
| FFA (μg/ml) | HC | SLE | p |
|---|---|---|---|
| Palmitic (16:0) | 32.76 (15.59) | 30.35 (8.37) | 0.982 |
| Stearic (18:0) | 28.51 (12.95) | 29.12 (6.19) | 0.873 |
| Palmitoleic (16:1ω7) | 1.93 (1.62) | 2.67 (0.99) | 0.351 |
| Oleic (18:1ω9) | 27.76 (20.61) | 34.39 (17.77) | 0.467 |
| Linoleic (18:2ω6) | 6.99 (6.47) | 10.26 (7.35) | 0.246 |
| γ-Linoleic (18:3ω6) | 0.08 (0.08) | 0.10 (0.06) | 0.785 |
| AA (20:4ω6) | 1.96 (1.68) | 2.74 (1.74) | 0.045 |
| Linolenic (18:3ω3) | 0.18 (0.17) | 0.20 (0.16) | 0.539 |
| EPA (20:5ω3) | 0.07 (0.15) | 0.15 (0.17) | 0.363 |
| DHA (22:6ω3) | 1.47 (1.46) | 1.65 (1.76) | 0.209 |
The differences in specific FFA serum levels between control and patients were assessed by Mann–Withney U tests. Variables are summarized as median (interquartile range). Statistical analyses with a p-value below 0.050 are highlighted in bold.